IDRA News Alert Idera Pharmaceuticals (IDRA) 4.04 12/06/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 6, 2014 at 11:18 PM

Idera Pharmaceuticals (IDRA) 4.04 $IDRA

The Biggest Risks For Stocks In 2015?
Leo Kolivakis - Seeking Alpha - Fri Dec 05, 3:07PM CST
Jeff Reeves, editor of InvestorPlace.com, wrote an article for MarketWatch, 10 biggest risks to the stock market in 2015 : It is shaping up to be another great year for stocks, with the S&P 500 up about 12% year-to-date in 2014 after a roughly...
KO: 43.53 (+0.03), XLB: 49.77 (-0.04), XBI: 181.28 (+3.17), IBB: 308.81 (+2.61), TLT: 121.09 (-0.71), GSG: 24.33 (-0.17), VOO: 190.80 (+0.34), PGNX: 7.26 (+0.01), IDRA: 4.04 (-0.02), QQQ: 105.38 (+0.01), XLK: 42.12 (-0.05), IWM: 117.69 (+0.88), CL: 69.37 (-0.08), XLE: 80.28 (-0.97)

Hawaiian Electric and Taser are big market movers
AP - Thu Dec 04, 3:35PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
TSLA: 223.71 (-4.57), HE: 32.78 (+0.56), PLUG: 3.60 (-0.10), CLV: 7.54 (-0.01), CLF: 7.97 (-0.06), BKS: 22.63 (+1.60), ARO: 2.46 (-0.02), RAD: 5.69 (+0.11), CARB: 14.38 (+0.17), SQNM: 3.77 (+0.10), ENB.TO: 58.46 (-1.58), RIG: 18.72 (+0.04), IDRA: 4.04 (-0.02), ANF: 27.29 (-0.61), ENB: 51.15 (-1.65), TASR: 24.82 (+0.67), AVGO: 103.99 (+0.92), PBYI: 205.94 (+10.39)

Traders Get Bullish on Shares of Idera Pharmaceuticals, Shares Up 7.0% (IDRA)
Comtex SmarTrend(R) - Wed Dec 03, 10:36AM CST
Idera Pharmaceuticals (NASDAQ:IDRA) is one of today's best performing low-priced stocks, up 7.0% to $3.83 on 3.7x average daily volume. Idera Pharmaceuticals has traded 2.7 million shares thus far today, vs. average volume of 727,000 shares per day. The stock has outperformed the Dow (7.0% to the Dow's 0.1%) and outperformed the S&P 500 (7.0% to the S&P's 0.2%) during today's trading.
IDRA: 4.04 (-0.02)

Idera up on preclinical data
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 9:47AM CST

IDRA: 4.04 (-0.02)

Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent and Systemic Anti-Tumor Activity in Preclinical Models
GlobeNewswire - Tue Dec 02, 3:30PM CST
Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, today announced new preclinical data that showed cancer immunotherapy with intratumoral injections of IMO-2055 and ipilimumab demonstrated potent and systemic anti-tumor activity in multiple preclinical cancer models. IMO-2055 is a synthetic oligonucleotide-based agonist of Toll-like receptor (TLR) 9 discovered and developed by Idera. Ipilimumab is a checkpoint inhibitor targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). The data were presented at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy Meeting in Orlando, Fla., earlier today.
IDRA: 4.04 (-0.02)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 11:47AM CST

CY: 13.02 (+0.54), QDEL: 24.95 (+0.94), WLT: 1.73 (-0.05), VNCE: 28.09 (-1.64), ISNS: 4.00 (+0.94), VII: 1.97 (+0.41), NTLS: 4.22 (-0.34), MFRM: 61.61 (-0.46), GSAT: 2.77 (+0.06), MOLG: 2.80 (-0.05), EVOK: 5.82 (-0.11), IDRA: 4.04 (-0.02), SCVL: 23.77 (unch), VGGL: 3.63 (-0.05), MIXT: 7.30 (-0.15), ENVI: 1.25 (unch), REI: 9.11 (-0.23), TRX: 0.86 (-0.02), DGLY: 19.83 (-1.17), CODE: 30.13 (+1.12)

Idera Announces Appointment of Robert A. Doody Jr. as Vice President of Investor Relations and Corporate Communications
GlobeNewswire - Tue Dec 02, 9:50AM CST
Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for cancers and rare diseases, announced that it has appointed Robert A. Doody Jr. as Vice President, Investor Relations and Corporate Communications.
IDRA: 4.04 (-0.02)

Idera Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Dec 02, 7:30AM CST
Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing novel nucleic acid therapeutics for cancer and rare diseases, today announced that Company management will present at the 26 Annual Piper Jaffray Healthcare Conference on Wednesday, December 3, 2014 at 3:30 p.m. EST in New York.
IDRA: 4.04 (-0.02)

Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer
GlobeNewswire - Mon Dec 01, 5:06PM CST
-- Appointment brings commercial, operational and financial expertise
IDRA: 4.04 (-0.02), VNDA: 12.30 (+0.03)

New Chief at Idera
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 3:54PM CST

IDRA: 4.04 (-0.02)

Idera Pharmaceuticals (IDRA) Is Today's Strong On High Volume Stock
at The Street - Fri Nov 28, 9:03AM CST
Trade-Ideas LLC identified Idera Pharmaceuticals (IDRA) as a strong on high relative volume candidate
IDRA: 4.04 (-0.02)

Idera Pharmaceuticals: A Star In The Making
Samreen Agha - at Seeking Alpha - Wed Nov 26, 11:46AM CST

IDRA: 4.04 (-0.02)

Hot Stock: Idera Pharmaceuticals, Shares Gain 8.2% (IDRA)
Comtex SmarTrend(R) - Wed Nov 26, 10:05AM CST
Idera Pharmaceuticals (NASDAQ:IDRA) is one of today's best performing low-priced stocks, up 8.2% to $3.03 on 2.5x average daily volume. Idera Pharmaceuticals has traded 1.7 million shares thus far today, vs. average volume of 665,000 shares per day. The stock has outperformed the Dow (8.2% to the Dow's -0.1%) and outperformed the S&P 500 (8.2% to the S&P's 0.1%) during today's trading.
IDRA: 4.04 (-0.02)

Are Central Banks Panicking?
Leo Kolivakis - Seeking Alpha - Fri Nov 21, 12:50PM CST
Koh Gui Qing and Jason Subler of Reuters report, China surprises with interest rate cut to spur growth : China cut interest rates unexpectedly on Friday, stepping up efforts to support the world's second-biggest economy as it heads towards its...
PGNX: 7.26 (+0.01), BCRX: 10.27 (+0.35), AVNR: 16.99 (+0.03), ACAD: 31.16 (+0.70), IDRA: 4.04 (-0.02), QQQ: 105.38 (+0.01), SGEN: 36.10 (-0.40), XBI: 181.28 (+3.17), TGTX: 13.80 (-0.04), IBB: 308.81 (+2.61), THLD: 3.22 (+0.22), IWM: 117.69 (+0.88), TWTR: 38.49 (-0.30), XOMA: 4.66 (+0.20)

Idera Pharmaceuticals to Present at the Stifel 2014 Healthcare Conference
GlobeNewswire - Thu Nov 13, 7:30AM CST
Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing novel nucleic acid therapeutics for rare diseases, today announced that Company management will present at the Stifel 2014 Healthcare Conference on Wednesday, November 19, 2014 at 4:10 p.m. EST in New York.
IDRA: 4.04 (-0.02)

Idera Pharmaceuticals' (IDRA) CEO Sudhir Agrawal on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 11, 10:52PM CST

IDRA: 4.04 (-0.02)

Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST

CANF: 4.02 (-0.02), JNJ: 108.51 (+0.95), IDRA: 4.04 (-0.02), DERM: 17.50 (+0.28), MRK: 61.49 (+0.57), PFE: 31.99 (+0.32), AZN: 73.72 (-0.22), AMGN: 169.24 (+2.69), GSK: 46.04 (+0.15), HSP: 60.10 (+0.84), NVS: 95.83 (+0.06), CELG: 114.13 (+0.50)

Idera ups revenues 329% in Q3
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 7:00AM CST

IDRA: 4.04 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Metriport Eyes Major Step in Health Data Integration

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

EnGenius Names Experienced VP to Boost Sales Growth

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Guaranteed Roof Expands with EM Exteriors through LB Capital

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

EmpowHer Grants Propel Female-led Social Ventures Forward

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Andover Audio's FreePlay: Stereo Sound Goes Portable

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Chad Tucker's Sequel Explores Deep Spiritual Themes

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

American Savings Bank Surges 6% on NYSE Debut

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...